Fate Therapeutics (FATE)

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

Fate Therapeutics files $300M mixed securities shelf (NASDAQ:FATE)

From Seeking Alpha Nov 9, 2023

Fate Therapeutics files preliminary prospectus for mixed shelf offering, aiming to raise $300M; not an offer to sell securities.

MVIS, DHC and RUM are among after hour movers (NASDAQ:FATE)

From Seeking Alpha Aug 28, 2023

Gainers: Fate Therapeutics (FATE) +5%. Diversified Healthcare (DHC) +4%

Fate Therapeutics GAAP EPS of -$0.54 beats by $0.06, revenue of $0.93M misses by $4.81M (NASDAQ:FATE)

From Seeking Alpha Aug 8, 2023

Fate Therapeutics press release (NASDAQ:FATE): Q2 GAAP EPS of -$0.54 beats by $0.06.Revenue of $0.93M (-95.0% Y/Y) misses by $4.81M.

Why Shares of Fate Therapeutics Soared This Week

From The Motley Fool Jun 16, 2023

The company's shares bounced back after a stock sale last week.

Fate Therapeutics GAAP EPS of -$0.19 beats by $0.47, revenue of $58.98M beats by $25.45M (NASDAQ:FATE)

From Seeking Alpha May 3, 2023

Fate Therapeutics press release (NASDAQ:FATE): Q1 GAAP EPS of -$0.19 beats by $0.47.Revenue of $58.98M (+220.5% Y/Y) beats by $25.45M.

Fate Therapeutics (FATE) Gets a Buy from H.C. Wainwright

From TipRanks Nov 21, 2022

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Fate Therapeutics (FATE – Research Report), with a price target of $1...

Fate Therapeutics (FATE)

Billionaire Steve Cohen Is Betting Big on Fate Therapeutics (FATE) Stock

CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC

Why Is Fate Therapeutics (FATE) Stock Down 62% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Fate Therapeutics (FATE)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

FATE Stock Predictions, Articles, and Fate Therapeutics News

Subscriber Sign in